Shares of Liquidia Corporation (NASDAQ:LQDA – Get Free Report) reached a new 52-week high on Monday . The stock traded as high as $80.79 and last traded at $79.2730, with a volume of 80378 shares traded. The stock had previously closed at $78.93.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on LQDA. BTIG Research raised their target price on Liquidia from $59.00 to $109.00 and gave the company a “buy” rating in a research report on Monday, June 22nd. Wall Street Zen downgraded shares of Liquidia from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 27th. Jefferies Financial Group restated a “buy” rating and set a $60.00 price target on shares of Liquidia in a research report on Monday, May 11th. Oppenheimer set a $75.00 price objective on shares of Liquidia in a report on Friday, June 5th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Liquidia in a research report on Tuesday, April 21st. Three investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $68.88.
Check Out Our Latest Report on Liquidia
Liquidia Trading Up 1.6%
Liquidia (NASDAQ:LQDA – Get Free Report) last issued its earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.11. The firm had revenue of $132.87 million for the quarter, compared to analyst estimates of $119.44 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The firm’s revenue was up 4187.1% on a year-over-year basis. On average, equities research analysts anticipate that Liquidia Corporation will post 3.02 earnings per share for the current fiscal year.
Insider Activity at Liquidia
In related news, insider Sanjeev Khindri sold 4,134 shares of the company’s stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $65.46, for a total transaction of $270,611.64. Following the sale, the insider directly owned 67,132 shares in the company, valued at approximately $4,394,460.72. This represents a 5.80% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stephen M. Bloch sold 100,000 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $75.74, for a total transaction of $7,574,000.00. Following the completion of the transaction, the director directly owned 880,073 shares of the company’s stock, valued at approximately $66,656,729.02. This trade represents a 10.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 2,302,030 shares of company stock worth $132,996,894. Company insiders own 25.60% of the company’s stock.
Hedge Funds Weigh In On Liquidia
A number of large investors have recently made changes to their positions in LQDA. Apis Capital Advisors LLC bought a new position in Liquidia in the 3rd quarter worth about $9,569,000. GSA Capital Partners LLP grew its holdings in Liquidia by 63.6% during the 4th quarter. GSA Capital Partners LLP now owns 63,176 shares of the company’s stock valued at $2,179,000 after buying an additional 24,555 shares in the last quarter. Farallon Capital Management LLC increased its position in shares of Liquidia by 102.1% during the third quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company’s stock valued at $194,783,000 after buying an additional 4,326,876 shares during the period. Tudor Investment Corp ET AL bought a new stake in shares of Liquidia during the third quarter valued at about $1,536,000. Finally, State of New Jersey Common Pension Fund D bought a new stake in shares of Liquidia during the fourth quarter valued at about $709,000. 64.54% of the stock is owned by institutional investors.
Liquidia Company Profile
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Featured Articles
- Five stocks we like better than Liquidia
- AI Is Selling Off, But These 5 Stocks Could Benefit Next
- These 3 Stocks Offer Investors Exposure to the Functional Beverage Boom
- Alcoa’s $4.1 Billion South32 Deal: Opportunity Behind the 9% Drop
- 3 High-Yield Dividend Stocks With Real Capital Gains Potential in 2026
Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.
